A doctoral research at the University of São Paulo has found that compounds in green propolis may help combat neurodegenerative diseases such as Alzheimer and Parkinson.
A recent doctoral study conducted at the Faculty of Pharmaceutical Sciences of Ribeirão Preto at the University of São Paulo (USP) has uncovered promising properties of green propolis, a substance produced by bees, in fighting neurodegenerative diseases like Alzheimer and Parkinson. The research involved laboratory tests which demonstrated that specific compounds in green propolis have the potential to protect nerve cells from damage and cell death, indicating that these substances may inhibit processes associated with neurological degeneration.
The study focused on the extraction of compounds known as artepelin C and bacarina, revealing that they can stimulate neurons to differentiate, connect, and prevent cellular loss. This discovery suggests that the components of green propolis could play a role in maintaining brain cell functionality by mitigating damage caused by degenerative processes. The findings were published in the scientific journal Chemistry & Biodiversity, reinforcing the significance of the research in the field of neuropharmacology.
These findings not only highlight the potential therapeutic benefits of green propolis but also open avenues for further research into natural compounds that may aid in treating or preventing neurodegenerative diseases. Given the increasing prevalence of conditions like Alzheimer and Parkinson worldwide, the implications of this study could be significant for public health, encouraging further exploration and validation in clinical settings.
